ESTRELLA IMMUNOPHARMA, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 24.6% | 24.6% | -0.5% |
| FY2022 | 44.2% | 44.2% | -10.2% |
| FY2023 | 94.7% | 94.7% | -367.0% |
| FY2024 | -5,087.1% | -5,087.1% | -232.8% |
| FY2025 | 126.0% | 126.0% | -411.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 24.6% | 24.6% | -0.5% |
| FY2022 | 44.2% | 44.2% | -10.2% |
| FY2023 | 94.7% | 94.7% | -367.0% |
| FY2024 | -5,087.1% | -5,087.1% | -232.8% |
| FY2025 | 126.0% | 126.0% | -411.2% |